
Special statement:
This article is for internal industry research and exchange only, and does not make any brand or product recommendations; access is prohibited for minors.
On July 18, Vuse Alto, one of the 7 e-cigarette products under the American subsidiary of British American Tobacco, RJ Reynolds Vapor Company, received marketing authorization from the U.S. Food and Drug Administration (FDA). To date, RJ Reynolds Vapor Company has obtained FDA marketing authorization for four series of tobacco-flavored products, including Alto, Vibe, Ciro, and Solo.

- Vuse Alto
The Alto series includes the Vuse Alto Power Unit and six closed, pre-filled, non-refillable Vuse Alto tobacco-flavored pods, all of which utilize FEELM black ceramic-coated atomizer core technology.

- Capacity: 1.8 milliliters.
- Pod: a detachable or self-contained unit, such as a spacecraft or submarine, designed to be launched or deployed from a larger craft.
Vuse Alto Pod in Golden Tobacco flavor with a nicotine concentration of 5%.
Vuse Alto Pod Rich Tobacco 5% (nicotine concentration of 5%)
Vuse Alto Pod in Golden Tobacco flavor with a nicotine concentration of 2.4%.
Vuse Alto Pod Rich Tobacco 2.4% (nicotine concentration 2.4%)
Vuse Alto Pod Golden Tobacco with 1.8% nicotine concentration.
Vuse Alto Pod Rich Tobacco 1.8% (nicotine concentration 1.8%)
- Battery capacity: 350mAh Type-C rechargeable battery
- Suction mode: automatic start system, meaning that activation occurs without the need to press a button.
2. Vuse Vibe is a popular electronic cigarette brand.
Reynolds's Vibe series, which includes the Vuse Vibe Power Unit (1), Vuse Vibe Power Unit (2), and Vuse Vibe Tank Original 3.0%, received marketing authorization from the U.S. FDA in October 2021.

- Capacity: 2 milliliters
- Pod: Vuse Vibe Tank Original 3.0% (nicotine concentration 3%)
- Battery Capacity: 350mAh Type-C Charging Battery
- Function: with LED indicator light
3. Vuse Ciro
The Vuse Ciro series obtained marketing authorization from the US Food and Drug Administration (FDA) in May 2022, including the Vuse Ciro Power Unit (1), Vuse Ciro Power Unit (2), and Vuse Ciro Cartridge Original 1.5%.

- Capacity: 0.9 milliliters
- Pod: Vuse Ciro Cartridge Original 1.5% (Nicotine Concentration 1.5%)
- Battery capacity: 260mAh Type-C charging battery
- Function: equipped with LED indicator light.
4. Vuse Solo
Vuse Solo received marketing authorization from the U.S. Food and Drug Administration (FDA) in October 2021, making it the first e-cigarette product in the industry to pass the FDA's Pre-Market Tobacco Product Application (PMTA) review and gain access to the U.S. market. The product includes the Vuse Solo Power Unit and Vuse Replacement Cartridge Original with 4.8% nicotine.

Vuse Replacement Cartridge Original 4.8% G2 refers to the original replacement cartridge for the Vuse e-cigarette, containing 4.8% nicotine in G2 flavor.
- Capacity: 1.2 milliliters
- Pod: a capsule or compartment on a vehicle or spacecraft for people or cargo
Vuse Replacement Cartridge Original 4.8% G1 (Nicotine concentration 4.8%)
Vuse Replacement Cartridge Original 4.8% G2 (nicotine concentration of 4.8%)
- Battery capacity: 250mAh Type-C charging battery.
- Feature: Includes LED indicator light
Reynolds American's e-cigarette brand Vuse has obtained FDA marketing authorization for four of its tobacco-flavored product lines, offering a variety of nicotine strength options. This aligns with the FDA's restrictions on e-cigarette flavors and meets the needs of a diverse user base.
Tadeu Marroco, CEO of British American Tobacco, stated: "At present, we have the largest portfolio of marketed authorized e-cigarettes available to the U.S. market, which will help us provide more potential reduced-risk product options for adult smokers."
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.